The team behind TOXsIgN has invested considerable time, resources, and effort into collecting, curating, processing, developing, and maintaining this web resource.
×
TSP48962-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to voxtalisib TSA208849-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib TSA208886-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib TSA208927-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib TSA208974-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib TSA209027-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib TSA209080-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib TSA209125-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to voxtalisib TSA209178-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib TSA209226-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib TSA209258-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib TSA209308-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib TSA209348-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to voxtalisib TSA209395-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib TSF473056-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 10.0 µM for 24.0 h 1 subfactor(s) TSF473057-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 3.33 µM for 24.0 h 1 subfactor(s) TSF473058-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 1.11 µM for 24.0 h 1 subfactor(s) TSF473059-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 0.37 µM for 24.0 h 1 subfactor(s) TSF473060-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 0.125 µM for 24.0 h 1 subfactor(s) TSF473061-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 0.04 µM for 24.0 h 1 subfactor(s) TSF577462-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 2.22 µM for 24.0 h 1 subfactor(s) TSF577463-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 0.74 µM for 24.0 h 1 subfactor(s) TSF577464-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 0.25 µM for 24.0 h 1 subfactor(s) TSF577465-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 0.08 µM for 24.0 h 1 subfactor(s) TSF577466-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 0.03 µM for 24.0 h 1 subfactor(s) TSF577467-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 0.01 µM for 24.0 h 1 subfactor(s) TSF473343-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 0.04 µM for 24.0 h 1 subfactor(s) TSF473339-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 3.33 µM for 24.0 h 1 subfactor(s) TSF473338-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 10.0 µM for 24.0 h 1 subfactor(s) TSF473340-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 1.11 µM for 24.0 h 1 subfactor(s) TSF473341-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 0.37 µM for 24.0 h 1 subfactor(s) TSF473342-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 0.125 µM for 24.0 h 1 subfactor(s) TSF577795-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 2.22 µM for 24.0 h 1 subfactor(s) TSF577799-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 0.01 µM for 24.0 h 1 subfactor(s) TSF577796-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 0.25 µM for 24.0 h 1 subfactor(s) TSF577797-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 0.08 µM for 24.0 h 1 subfactor(s) TSF577798-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 0.03 µM for 24.0 h 1 subfactor(s) TSF473620-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 10.0 µM for 24.0 h 1 subfactor(s) TSF473621-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 3.33 µM for 24.0 h 1 subfactor(s) TSF473622-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 1.11 µM for 24.0 h 1 subfactor(s) TSF473623-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 0.37 µM for 24.0 h 1 subfactor(s) TSF473624-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 0.125 µM for 24.0 h 1 subfactor(s) TSF473625-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 0.04 µM for 24.0 h 1 subfactor(s) TSF578120-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 2.22 µM for 24.0 h 1 subfactor(s) TSF578124-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 0.03 µM for 24.0 h 1 subfactor(s) TSF578121-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 0.74 µM for 24.0 h 1 subfactor(s) TSF578122-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 0.25 µM for 24.0 h 1 subfactor(s) TSF578123-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 0.08 µM for 24.0 h 1 subfactor(s) TSF578125-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 0.01 µM for 24.0 h 1 subfactor(s) TSF473914-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 10.0 µM for 24.0 h 1 subfactor(s) TSF473915-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 3.33 µM for 24.0 h 1 subfactor(s) TSF473916-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 1.11 µM for 24.0 h 1 subfactor(s) TSF473917-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 0.37 µM for 24.0 h 1 subfactor(s) TSF473918-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 0.125 µM for 24.0 h 1 subfactor(s) TSF473919-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 0.04 µM for 24.0 h 1 subfactor(s) TSF578456-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 2.22 µM for 24.0 h 1 subfactor(s) TSF578460-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 0.03 µM for 24.0 h 1 subfactor(s) TSF578457-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 0.74 µM for 24.0 h 1 subfactor(s) TSF578458-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 0.25 µM for 24.0 h 1 subfactor(s) TSF578459-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 0.08 µM for 24.0 h 1 subfactor(s) TSF578461-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 0.01 µM for 24.0 h 1 subfactor(s) TSF474237-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 1.11 µM for 24.0 h 1 subfactor(s) TSF474235-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 10.0 µM for 24.0 h 1 subfactor(s) TSF474236-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 3.33 µM for 24.0 h 1 subfactor(s) TSF474238-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 0.37 µM for 24.0 h 1 subfactor(s) TSF474239-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 0.125 µM for 24.0 h 1 subfactor(s) TSF474240-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 0.04 µM for 24.0 h 1 subfactor(s) TSF578794-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 0.01 µM for 24.0 h 1 subfactor(s) TSF578790-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 0.74 µM for 24.0 h 1 subfactor(s) TSF578789-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 2.22 µM for 24.0 h 1 subfactor(s) TSF578791-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 0.25 µM for 24.0 h 1 subfactor(s) TSF578792-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 0.08 µM for 24.0 h 1 subfactor(s) TSF578793-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 0.03 µM for 24.0 h 1 subfactor(s) TSF474560-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 0.04 µM for 24.0 h 1 subfactor(s) TSF474556-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 3.33 µM for 24.0 h 1 subfactor(s) TSF474555-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 10.0 µM for 24.0 h 1 subfactor(s) TSF474557-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 1.11 µM for 24.0 h 1 subfactor(s) TSF474558-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 0.37 µM for 24.0 h 1 subfactor(s) TSF474559-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 0.125 µM for 24.0 h 1 subfactor(s) TSF579126-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 0.74 µM for 24.0 h 1 subfactor(s) TSF579125-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 2.22 µM for 24.0 h 1 subfactor(s) TSF579129-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 0.03 µM for 24.0 h 1 subfactor(s) TSF579127-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 0.25 µM for 24.0 h 1 subfactor(s) TSF579128-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 0.08 µM for 24.0 h 1 subfactor(s) TSF579130-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 0.01 µM for 24.0 h 1 subfactor(s) TSF474848-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to voxtalisib 10.0 µM for 24.0 h 1 subfactor(s) TSF474853-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to voxtalisib 0.04 µM for 24.0 h 1 subfactor(s) TSF474849-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to voxtalisib 3.33 µM for 24.0 h 1 subfactor(s) TSF474850-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to voxtalisib 1.11 µM for 24.0 h 1 subfactor(s) TSF474851-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to voxtalisib 0.37 µM for 24.0 h 1 subfactor(s) TSF474852-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to voxtalisib 0.125 µM for 24.0 h 1 subfactor(s) TSF475166-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 10.0 µM for 24.0 h 1 subfactor(s) TSF475167-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 3.33 µM for 24.0 h 1 subfactor(s) TSF475168-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 1.11 µM for 24.0 h 1 subfactor(s) TSF475169-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 0.37 µM for 24.0 h 1 subfactor(s) TSF475170-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 0.125 µM for 24.0 h 1 subfactor(s) TSF475171-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 0.04 µM for 24.0 h 1 subfactor(s) TSF579456-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 2.22 µM for 24.0 h 1 subfactor(s) TSF579457-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 0.74 µM for 24.0 h 1 subfactor(s) TSF579458-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 0.25 µM for 24.0 h 1 subfactor(s) TSF579459-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 0.08 µM for 24.0 h 1 subfactor(s) TSF579460-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 0.03 µM for 24.0 h 1 subfactor(s) TSF579461-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 0.01 µM for 24.0 h 1 subfactor(s) TSF475477-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 0.125 µM for 24.0 h 1 subfactor(s) TSF475473-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 10.0 µM for 24.0 h 1 subfactor(s) TSF475474-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 3.33 µM for 24.0 h 1 subfactor(s) TSF475475-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 1.11 µM for 24.0 h 1 subfactor(s) TSF475476-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 0.37 µM for 24.0 h 1 subfactor(s) TSF475478-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 0.04 µM for 24.0 h 1 subfactor(s) TSF579788-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 0.03 µM for 24.0 h 1 subfactor(s) TSF579784-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 2.22 µM for 24.0 h 1 subfactor(s) TSF579789-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 0.01 µM for 24.0 h 1 subfactor(s) TSF579785-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 0.74 µM for 24.0 h 1 subfactor(s) TSF579786-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 0.25 µM for 24.0 h 1 subfactor(s) TSF579787-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 0.08 µM for 24.0 h 1 subfactor(s) TSF475753-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 10.0 µM for 24.0 h 1 subfactor(s) TSF475754-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 3.33 µM for 24.0 h 1 subfactor(s) TSF475755-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 1.11 µM for 24.0 h 1 subfactor(s) TSF475756-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 0.37 µM for 24.0 h 1 subfactor(s) TSF475757-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 0.125 µM for 24.0 h 1 subfactor(s) TSF475758-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 0.04 µM for 24.0 h 1 subfactor(s) TSF580117-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 2.22 µM for 24.0 h 1 subfactor(s) TSF580118-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 0.74 µM for 24.0 h 1 subfactor(s) TSF580121-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 0.03 µM for 24.0 h 1 subfactor(s) TSF580119-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 0.25 µM for 24.0 h 1 subfactor(s) TSF580120-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 0.08 µM for 24.0 h 1 subfactor(s) TSF580122-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 0.01 µM for 24.0 h 1 subfactor(s) TSF476062-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 0.37 µM for 24.0 h 1 subfactor(s) TSF476059-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 10.0 µM for 24.0 h 1 subfactor(s) TSF476060-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 3.33 µM for 24.0 h 1 subfactor(s) TSF476063-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 0.125 µM for 24.0 h 1 subfactor(s) TSF476061-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 1.11 µM for 24.0 h 1 subfactor(s) TSF476064-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 0.04 µM for 24.0 h 1 subfactor(s) TSF580452-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 2.22 µM for 24.0 h 1 subfactor(s) TSF580453-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 0.74 µM for 24.0 h 1 subfactor(s) TSF580454-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 0.25 µM for 24.0 h 1 subfactor(s) TSF580455-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 0.08 µM for 24.0 h 1 subfactor(s) TSF580456-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 0.03 µM for 24.0 h 1 subfactor(s) TSF580457-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 0.01 µM for 24.0 h 1 subfactor(s) TSF476339-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to voxtalisib 10.0 µM for 24.0 h 1 subfactor(s) TSF476340-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to voxtalisib 3.33 µM for 24.0 h 1 subfactor(s) TSF476341-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to voxtalisib 1.11 µM for 24.0 h 1 subfactor(s) TSF476342-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to voxtalisib 0.37 µM for 24.0 h 1 subfactor(s) TSF476343-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to voxtalisib 0.125 µM for 24.0 h 1 subfactor(s) TSF476344-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to voxtalisib 0.04 µM for 24.0 h 1 subfactor(s) TSF476649-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 10.0 µM for 24.0 h 1 subfactor(s) TSF476654-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 0.04 µM for 24.0 h 1 subfactor(s) TSF476650-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 3.33 µM for 24.0 h 1 subfactor(s) TSF476651-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 1.11 µM for 24.0 h 1 subfactor(s) TSF476652-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 0.37 µM for 24.0 h 1 subfactor(s) TSF476653-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 0.125 µM for 24.0 h 1 subfactor(s) TSF580785-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 0.08 µM for 24.0 h 1 subfactor(s) TSF580786-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 0.03 µM for 24.0 h 1 subfactor(s) TSF580782-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 2.22 µM for 24.0 h 1 subfactor(s) TSF580783-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 0.74 µM for 24.0 h 1 subfactor(s) TSF580784-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 0.25 µM for 24.0 h 1 subfactor(s) TSF580787-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 0.01 µM for 24.0 h 1 subfactor(s) TSS473065-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 10.0 µM for 24.0 h TSS473066-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 3.33 µM for 24.0 h TSS473067-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 1.11 µM for 24.0 h TSS473068-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 0.37 µM for 24.0 h TSS473069-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 0.125 µM for 24.0 h TSS473070-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 0.04 µM for 24.0 h TSS577472-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 2.22 µM for 24.0 h TSS577473-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 0.74 µM for 24.0 h TSS577474-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 0.25 µM for 24.0 h TSS577475-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 0.08 µM for 24.0 h TSS577476-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 0.03 µM for 24.0 h TSS577477-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to voxtalisib 0.01 µM for 24.0 h TSS473352-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 0.04 µM for 24.0 h TSS473348-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 3.33 µM for 24.0 h TSS473347-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 10.0 µM for 24.0 h TSS473349-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 1.11 µM for 24.0 h TSS473350-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 0.37 µM for 24.0 h TSS473351-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 0.125 µM for 24.0 h TSS577805-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 2.22 µM for 24.0 h TSS577809-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 0.01 µM for 24.0 h TSS577806-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 0.25 µM for 24.0 h TSS577807-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 0.08 µM for 24.0 h TSS577808-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to voxtalisib 0.03 µM for 24.0 h TSS473629-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 10.0 µM for 24.0 h TSS473630-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 3.33 µM for 24.0 h TSS473631-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 1.11 µM for 24.0 h TSS473632-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 0.37 µM for 24.0 h TSS473633-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 0.125 µM for 24.0 h TSS473634-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 0.04 µM for 24.0 h TSS578130-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 2.22 µM for 24.0 h TSS578134-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 0.03 µM for 24.0 h TSS578131-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 0.74 µM for 24.0 h TSS578132-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 0.25 µM for 24.0 h TSS578133-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 0.08 µM for 24.0 h TSS578135-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to voxtalisib 0.01 µM for 24.0 h TSS473923-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 10.0 µM for 24.0 h TSS473924-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 3.33 µM for 24.0 h TSS473925-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 1.11 µM for 24.0 h TSS473926-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 0.37 µM for 24.0 h TSS473927-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 0.125 µM for 24.0 h TSS473928-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 0.04 µM for 24.0 h TSS578466-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 2.22 µM for 24.0 h TSS578470-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 0.03 µM for 24.0 h TSS578467-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 0.74 µM for 24.0 h TSS578468-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 0.25 µM for 24.0 h TSS578469-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 0.08 µM for 24.0 h TSS578471-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to voxtalisib 0.01 µM for 24.0 h TSS474246-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 1.11 µM for 24.0 h TSS474244-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 10.0 µM for 24.0 h TSS474245-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 3.33 µM for 24.0 h TSS474247-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 0.37 µM for 24.0 h TSS474248-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 0.125 µM for 24.0 h TSS474249-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 0.04 µM for 24.0 h TSS578804-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 0.01 µM for 24.0 h TSS578800-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 0.74 µM for 24.0 h TSS578799-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 2.22 µM for 24.0 h TSS578801-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 0.25 µM for 24.0 h TSS578802-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 0.08 µM for 24.0 h TSS578803-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to voxtalisib 0.03 µM for 24.0 h TSS474569-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 0.04 µM for 24.0 h TSS474565-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 3.33 µM for 24.0 h TSS474564-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 10.0 µM for 24.0 h TSS474566-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 1.11 µM for 24.0 h TSS474567-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 0.37 µM for 24.0 h TSS474568-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 0.125 µM for 24.0 h TSS579136-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 0.74 µM for 24.0 h TSS579135-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 2.22 µM for 24.0 h TSS579139-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 0.03 µM for 24.0 h TSS579137-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 0.25 µM for 24.0 h TSS579138-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 0.08 µM for 24.0 h TSS579140-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to voxtalisib 0.01 µM for 24.0 h TSS474857-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to voxtalisib 10.0 µM for 24.0 h TSS474862-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to voxtalisib 0.04 µM for 24.0 h TSS474858-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to voxtalisib 3.33 µM for 24.0 h TSS474859-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to voxtalisib 1.11 µM for 24.0 h TSS474860-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to voxtalisib 0.37 µM for 24.0 h TSS474861-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to voxtalisib 0.125 µM for 24.0 h TSS475175-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 10.0 µM for 24.0 h TSS475176-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 3.33 µM for 24.0 h TSS475177-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 1.11 µM for 24.0 h TSS475178-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 0.37 µM for 24.0 h TSS475179-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 0.125 µM for 24.0 h TSS475180-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 0.04 µM for 24.0 h TSS579466-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 2.22 µM for 24.0 h TSS579467-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 0.74 µM for 24.0 h TSS579468-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 0.25 µM for 24.0 h TSS579469-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 0.08 µM for 24.0 h TSS579470-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 0.03 µM for 24.0 h TSS579471-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to voxtalisib 0.01 µM for 24.0 h TSS475486-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 0.125 µM for 24.0 h TSS475482-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 10.0 µM for 24.0 h TSS475483-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 3.33 µM for 24.0 h TSS475484-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 1.11 µM for 24.0 h TSS475485-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 0.37 µM for 24.0 h TSS475487-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 0.04 µM for 24.0 h TSS579798-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 0.03 µM for 24.0 h TSS579794-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 2.22 µM for 24.0 h TSS579799-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 0.01 µM for 24.0 h TSS579795-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 0.74 µM for 24.0 h TSS579796-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 0.25 µM for 24.0 h TSS579797-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to voxtalisib 0.08 µM for 24.0 h TSS475762-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 10.0 µM for 24.0 h TSS475763-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 3.33 µM for 24.0 h TSS475764-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 1.11 µM for 24.0 h TSS475765-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 0.37 µM for 24.0 h TSS475766-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 0.125 µM for 24.0 h TSS475767-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 0.04 µM for 24.0 h TSS580127-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 2.22 µM for 24.0 h TSS580128-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 0.74 µM for 24.0 h TSS580131-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 0.03 µM for 24.0 h TSS580129-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 0.25 µM for 24.0 h TSS580130-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 0.08 µM for 24.0 h TSS580132-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to voxtalisib 0.01 µM for 24.0 h TSS476071-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 0.37 µM for 24.0 h TSS476068-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 10.0 µM for 24.0 h TSS476069-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 3.33 µM for 24.0 h TSS476072-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 0.125 µM for 24.0 h TSS476070-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 1.11 µM for 24.0 h TSS476073-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 0.04 µM for 24.0 h TSS580462-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 2.22 µM for 24.0 h TSS580463-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 0.74 µM for 24.0 h TSS580464-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 0.25 µM for 24.0 h TSS580465-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 0.08 µM for 24.0 h TSS580466-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 0.03 µM for 24.0 h TSS580467-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to voxtalisib 0.01 µM for 24.0 h TSS476348-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to voxtalisib 10.0 µM for 24.0 h TSS476349-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to voxtalisib 3.33 µM for 24.0 h TSS476350-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to voxtalisib 1.11 µM for 24.0 h TSS476351-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to voxtalisib 0.37 µM for 24.0 h TSS476352-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to voxtalisib 0.125 µM for 24.0 h TSS476353-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to voxtalisib 0.04 µM for 24.0 h TSS476658-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 10.0 µM for 24.0 h TSS476663-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 0.04 µM for 24.0 h TSS476659-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 3.33 µM for 24.0 h TSS476660-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 1.11 µM for 24.0 h TSS476661-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 0.37 µM for 24.0 h TSS476662-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 0.125 µM for 24.0 h TSS580795-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 0.08 µM for 24.0 h TSS580796-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 0.03 µM for 24.0 h TSS580792-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 2.22 µM for 24.0 h TSS580793-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 0.74 µM for 24.0 h TSS580794-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 0.25 µM for 24.0 h TSS580797-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to voxtalisib 0.01 µM for 24.0 h
TSP48962 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to voxtalisib
Public
https://clue.io/data/CMap2020#LINCS2020
Experimental design
No experimental design provided
Results
No results provided